COVID-19: Vaccines and Therapeutics
Health care leaders plead for people to get vaccinated and mask up to slow one of the Tennessee’s biggest COVID-19 surges.
Hospitals are using first-person testimonies from COVID-19 survivors to emphasize the importance of vaccinations.
Moderna announced the completion of its biologic license application to the Food and Drug Administration for its mRNA COVID-19 vaccine. The application comes with a request for priority review.
The AHA released new public service announcements and related digital content encouraging vaccination against COVID-19 by still-unvaccinated health care workers and members of the public.
The AHA today released new public service announcements (PSAs) and related digital content encouraging vaccination against COVID-19 by still-unvaccinated health care workers and members of the public. Hospitals and health systems can add their own branding, in both 30- and 15-second versions, for…
The Centers for Disease Control and Prevention released research highlighting two important trends emerging from the COVID-19 pandemic regarding vaccines’ current effectiveness.
Hospitals and health systems remain on the front lines of the COVID-19 pandemic and continue to play an important role in efforts to vaccinate their patients and communities.
During an Aug. 23 White House COVID-19 virtual town hall focused on vaccinations, leaders from CommonSpirit, Northwell…
The Food and Drug Administration today granted full approval for the Pfizer-BioNTech COVID-19 vaccine for individuals age 16 and over. The vaccine, which will now be marketed as Comirnaty, is the first COVID-19 vaccine to go beyond emergency use status in the United States.
The full approval of the Pfizer-BioNTech COVID-19 vaccine by the U.S. Food and Drug Administration (FDA) – the result of many months of work, robust data evaluation, and a thorough, comprehensive review process that has already protected more than one hundred million Americans from severe COVID-19…
The Food and Drug Administration granted full approval for the Pfizer-BioNTech COVID-19 vaccine for individuals age 16 and over.